Continuous flow left ventricular assist devices (CF-LVAD) have become one of the long-term treatment options for patients with end-stage heart failure. In such patients, ventricular arrhythmia (VA) is a common complication after implantation. Severe VA after CF-LVAD implantation can cause adverse events such as impaired right ventricular filling and hemodynamic deterioration, which in turn affects the patient's prognosis. By reviewing the relevant research progress of VA after CF-LVAD implantation, this article provides an overview of the epidemiology, perioperative management, and therapeutic options of postimplantation VA, aiming to summarize the pathogenesis, clinical manifestations, and prognostic outcomes of postimplantation VA, and to provide ideas for a more comprehensive and in-depth study.